These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4072874)

  • 21. Acute oral testing for determining antiarrhythmic drug efficacy. I. Quinidine.
    Gaughan CE; Lown B; Lanigan J; Voukydis P; Besser HW
    Am J Cardiol; 1976 Nov; 38(6):677-84. PubMed ID: 998504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encainide for ventricular arrhythmias: placebo-controlled and standard comparison trials.
    Morganroth J
    Am J Cardiol; 1986 Aug; 58(5):74C-82C. PubMed ID: 3092623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
    Shapiro W; Park J; Koch GG
    Am J Cardiol; 1982 Feb; 49(2):445-54. PubMed ID: 6174041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of lorcainide and quinidine in the treatment of ventricular ectopy.
    Vlay SC; Mallis GI; Singh S; Cohn PF
    Chest; 1984 Jul; 86(1):80-3. PubMed ID: 6734299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.
    Velebit V; Podrid P; Lown B; Cohen BH; Graboys TB
    Circulation; 1982 May; 65(5):886-94. PubMed ID: 6176355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Quinidine in the Pharmacological Therapy of Ventricular Arrhythmias 'Quinidine'.
    Bozic B; Uzelac TV; Kezic A; Bajcetic M
    Mini Rev Med Chem; 2018; 18(6):468-475. PubMed ID: 28685701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tocainide plus quinidine for treatment of ventricular arrhythmias.
    Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
    Am J Cardiol; 1988 Mar; 61(8):570-3. PubMed ID: 3125737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activity of a new long-acting anti-arrhythmic drug on ventricular extrasystole. Study with Holter continuous electrocardiographic monitoring].
    Romano S; Pozzoni L; Verzoni A; Lomuscio A; Guffanti E; Croce L
    G Ital Cardiol; 1981; 11(5):657-62. PubMed ID: 6169582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of the efficacy of aprindine and quinidine in chronic ventricular rhythm disorders].
    Leclercq JF; Attuel P; Milosevic D; Rosengarten MD; Coumel P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):923-30. PubMed ID: 6793009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative study of a slow-release quinidine preparation and flecainide administered in 2 daily doses for the treatment of extrasystole].
    Clémenty J; Castagne D; Dallocchio M; Bricaud H
    Ann Cardiol Angeiol (Paris); 1984 Oct; 33(6):401-5. PubMed ID: 6208841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioavailability of two manufacturers' sustained-release quinidine gluconate tablets at steady state.
    Zinny MA; Taggart WV
    Clin Ther; 1984; 7(1):22-7. PubMed ID: 6518461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma level studies of quinidine retard, their significance for dosage and onset of effect].
    Guckenbiehl W; Just H; Olbermann M; Lang KF
    Med Klin; 1976 Apr; 71(14):586-92. PubMed ID: 57566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A new long acting quinidine preparation].
    Heulin A; Delvaux JC; Vacheron A
    Coeur Med Interne; 1975; 14(1):145-6. PubMed ID: 1091404
    [No Abstract]   [Full Text] [Related]  

  • 35. Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias.
    Nielsen H; Sørum C; Rasmussen V; Madsen JK; Hansen JF
    Acta Cardiol; 1990; 45(5):359-63. PubMed ID: 1704168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of a twice-daily dosing regimen for moricizine (ethmozine).
    Morganroth J
    Am Heart J; 1985 Dec; 110(6):1188-92. PubMed ID: 3907314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
    Duff HJ; Roden D; Primm RK; Oates JA; Woosley RL
    Circulation; 1983 May; 67(5):1124-8. PubMed ID: 6831673
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of tocainide and quinidine on premature ventricular contractions.
    Wasenmiller JE; Aronow WS
    Clin Pharmacol Ther; 1980 Oct; 28(4):431-5. PubMed ID: 6773715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of antiarrhythmic therapy using Holter monitoring.
    Morganroth J
    Am J Cardiol; 1988 Oct; 62(12):18H-23H. PubMed ID: 3052004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
    Hohnloser SH; van de Loo A; Baedeker F
    J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.